Trials / Completed
CompletedNCT03184324
Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Erosive Gastroesophageal Reflux Disease (Phase 2, Therapeutic Exploratory Study)
A Multi-Center, Randomized, Double-Blind, Active-controlled, Phase 2, Therapeutic Exploratory Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Erosive Gastroesophageal Reflux Disease.
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 211 (actual)
- Sponsor
- Daewoong Pharmaceutical Co. LTD. · Industry
- Sex
- All
- Age
- 20 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the efficacy and safety of DWP14012 compared to esomeprazole in the treatment of erosive gastroesophageal reflux disease classified as Los Angeles(LA) classification grades A to D.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DWP14012 | tablet |
| DRUG | Esomeprazole | tablet |
| DRUG | DWP14012 placebo | tablet |
| DRUG | Esomeprazole placebo | tablet |
Timeline
- Start date
- 2017-08-28
- Primary completion
- 2018-04-18
- Completion
- 2018-04-18
- First posted
- 2017-06-12
- Last updated
- 2020-09-03
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03184324. Inclusion in this directory is not an endorsement.